Home Cart Sign in  
Chemical Structure| 104594-70-9 Chemical Structure| 104594-70-9

Structure of Phenethyl caffeate
CAS No.: 104594-70-9

Chemical Structure| 104594-70-9

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Caffeic acid phenethyl ester, a natural product isolated and purified from the barks of Cinnamomum cassia Presl, is a potent and specific inhibitor of NF-κB activation, and also displays antioxidant, immunomodulatory and antiinflammatory activities.

Synonyms: Caffeic acid phenethyl ester; CAPE; BAF-IN-C09

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Phenethyl caffeate

CAS No. :104594-70-9
Formula : C17H16O4
M.W : 284.31
SMILES Code : O=C(OCCC1=CC=CC=C1)/C=C/C2=CC=C(O)C(O)=C2
Synonyms :
Caffeic acid phenethyl ester; CAPE; BAF-IN-C09
MDL No. :MFCD00866470
InChI Key :SWUARLUWKZWEBQ-VQHVLOKHSA-N
Pubchem ID :5281787

Safety of Phenethyl caffeate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Phenethyl caffeate

pyroptosis

Isoform Comparison

Biological Activity

Target
  • NF-κB

In Vitro:

Cell Line
Concentration Treated Time Description References
HCT116 cells 10, 5, 2.5 mg/L 24 hours CAPE induced G0/G1 phase arrest and apoptosis in HCT116 cells, with apoptosis rates of 25.5±3.3%, 16.6±0.6%, 10.2±0.7%, respectively. World J Gastroenterol. 2005 Jul 14;11(26):4008-12
HCT116 cells 80, 40, 20, 10, 5, 2.5 mg/L 24, 48, 72, 96 hours CAPE inhibited HCT116 cell proliferation in a dose- and time-dependent manner, with IC50 values of 22.45, 12.07, 6.47, 5.36 mg/L, respectively. World J Gastroenterol. 2005 Jul 14;11(26):4008-12

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02744703 Matrix Metalloproteinase Inhib... More >>itors Composite Resins Less << Not Applicable Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.52mL

0.70mL

0.35mL

17.59mL

3.52mL

1.76mL

35.17mL

7.03mL

3.52mL

References

 

Historical Records

Categories